Evidence map›Paper›PMID 39119419›Full record

ArticleCureus2024

The Efficacy of a Ketogenic Diet in a Case With Febrile Infection-Related Epilepsy Syndrome in the Chronic Phase: A Case Report.

Shota Yoneno, Shimpei Baba, Noriko Sumitomo, Kayoko Miyamoto, Kan Takahashi, Yuko Shimizu-Motohashi, Takashi Saito, Hirofumi Komaki

Abstract readCase Reports
In one paragraph

Article in Cureus, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Vagus nerve stimulation and fast parameter programming protocol in children with febrile infection-related epilepsy syndrome in ICU.Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Shota YonenoDepartment of Child Neurology, National Center of Neurology and Psychiatry, Tokyo, JPN.
Shimpei BabaDepartment of Child Neurology, National Center of Neurology and Psychiatry, Tokyo, JPN.
Noriko SumitomoDepartment of Child Neurology, National Center of Neurology and Psychiatry, Tokyo, JPN.
Kayoko MiyamotoDepartment of Nutrition, National Center of Neurology and Psychiatry, Tokyo, JPN.
Kan TakahashiDepartment of Pediatrics, Ome Medical Center, Tokyo, JPN.
Yuko Shimizu-MotohashiDepartment of Child Neurology, National Center of Neurology and Psychiatry, Tokyo, JPN.
Takashi SaitoDepartment of Child Neurology, National Center of Neurology and Psychiatry, Tokyo, JPN.
Hirofumi KomakiDepartment of Child Neurology, National Center of Neurology and Psychiatry, Tokyo, JPN.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Although the treatment strategy for febrile infection-related epilepsy syndrome (FIRES) is improving, current research focuses on acute management. Evidence for the management of the chronic phase is limited. We present the case of a 19-year-old woman with FIRES who showed excellent response to a ketogenic diet (KD) administered in the chronic phase. At the age of four years, she presented with new-onset super-refractory status epilepticus after a febrile episode. She was diagnosed with FIRES and had profound motor and cognitive deterioration and drug-resistant epilepsy. From the age of 17, she experienced numerous seizures that often led to status epilepticus with respiratory failure, necessitating laryngotracheal separation and nocturnal mechanical ventilation. To improve seizure control, we planned a KD for the first time 15 years after the onset of FIRES. We introduced a classic KD (ketogenic ratio, 3:1) using blended meals through gastrotomy. Two months after starting the KD, she experienced a decrease in seizure frequency and duration. Moreover, as unexpected stabilization of respiration was achieved, mechanical ventilation was stopped. Our case implies that KD may be a promising treatment option for patients with FIRES in the chronic phase, as is believed to be the case in the acute phase.

Indexed as

chronic phasefebrile infection-related epilepsy syndrome (fires)improvement in respiratory functionketogenic dietsevere motor and intellectual disabilities

Identifiers

PMID39119419
PMCPMC11308749

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.